Luvadaxistat
Overview of the drug Luvadaxistat
Luvadaxistat is a pharmaceutical compound that functions as a reversible inhibitor of the enzyme D-amino acid oxidase (DAAO). It is primarily being investigated for its potential therapeutic effects in the treatment of schizophrenia and other neuropsychiatric disorders.
Mechanism of Action[edit | edit source]
Luvadaxistat works by inhibiting the activity of D-amino acid oxidase, an enzyme responsible for the degradation of D-serine, a co-agonist of the NMDA receptor. By inhibiting DAAO, luvadaxistat increases the levels of D-serine in the brain, which in turn enhances NMDA receptor function. This mechanism is thought to be beneficial in conditions like schizophrenia, where NMDA receptor hypofunction is implicated.
Clinical Development[edit | edit source]
Luvadaxistat is currently undergoing clinical trials to evaluate its efficacy and safety in the treatment of schizophrenia. The drug is being developed by Takeda Pharmaceuticals.
Phase I Trials[edit | edit source]
Initial phase I trials focused on assessing the safety, tolerability, and pharmacokinetics of luvadaxistat in healthy volunteers. These studies helped establish the appropriate dosing regimen for subsequent trials.
Phase II Trials[edit | edit source]
Phase II trials are designed to evaluate the efficacy of luvadaxistat in patients with schizophrenia. These studies aim to determine whether the drug can improve symptoms such as cognitive deficits and negative symptoms, which are often inadequately addressed by current antipsychotic medications.
Potential Benefits[edit | edit source]
The potential benefits of luvadaxistat in treating schizophrenia include improved cognitive function and reduction in negative symptoms. By enhancing NMDA receptor activity, luvadaxistat may address some of the underlying pathophysiological mechanisms of schizophrenia that are not targeted by traditional antipsychotics.
Side Effects[edit | edit source]
As with any pharmacological treatment, luvadaxistat may have side effects. Commonly reported side effects in clinical trials include headache, nausea, and dizziness. The safety profile of luvadaxistat continues to be evaluated in ongoing studies.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
